The Gambia

in page functions
[French]
Gambia
Total population (2018) 2,187,264
Birth cohort (2018) 88,168
Surviving Infants (surviving to 1 year per year, 2018) 84,452
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 48/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 69/1000
World Bank Index, IDA (2015) 2.93
Gross Nation Income (per capita US$, 2014) 460
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 7

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Gambia

Type of support

Approvals

2001-2022 (US$)
(20 Jul 2018)

Commitments

2001-2022 (US$)
(20 Jul 2018)

Disbursements

2000-2018 (US$)
(20 Jul 2018)

% Disbursed

(20 Jul 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $31,892,875 $38,635,916 $30,695,931
Cash Support (CASHSUPP) $195,000 $195,000 $195,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $533,087 $533,087
Health system strengthening (HSS 1) N/A
Health system strengthening (HSS 2) $3,284,459 $5,500,000 $1,574,306 48%
HepB mono (NVS) $455,977 $455,977 $455,977 100%
Hib mono (NVS) $410,021 $410,021 $410,021 100%
HPV (NVS) N/A
HPV Demo (NVS) $282,258 $282,258 $282,666 100%
HPV MAC (NVS) N/A
HPV MAC - Op costs (OPC) N/A
Immunisation services support (ISS) $671,640 $671,640 $671,640 100%
Injection Safety Devices (NVS) $72,000 $168,000 $89,927 125%
Injection safety support (INS) $101,184 $101,184 $101,184 100%
IPV (NVS) $203,279 $203,279 $166,779 82%
Measles (NVS) $139,080 $139,080 $139,774 100%
Measles-Rubella (NVS) $629,937 $629,937 $629,937 100%
Meningitis A (NVS) $75,500 $237,000 $81,120 107%
Meningitis A - campaign (NVS) $788,739 $788,739 $788,739 100%
Meningitis A - mini catch-up campaign (NVS) $223,500 $223,500 $234,867 105%
Meningitis A - mini catch-up op.costs (OPC) $198,424 $198,424 $198,424 100%
Meningitis A - operational costs (OPC) $727,500 $727,500 $727,500 100%
MR - Operational costs (OPC) $521,500 $521,500 $521,500 100%
Penta (NVS) $4,535,363 $4,974,363 $4,499,673 99%
Pneumo (NVS) $9,502,264 $12,330,264 $10,698,724 113%
Product Switch Grant (PSG) $29,999 $29,999 $29,999 100%
Rotavirus (NVS) $3,430,232 $4,433,232 $3,416,242 100%
Tetra DTP-Hib (NVS) $3,675,683 $3,675,683 $3,675,683 100%
Vaccine Introduction Grant (VIG) $1,206,249 $1,206,249 $1,106,249 92%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Gambia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 92%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2012) 89.10%
Household survey: DTP3 coverage for female (2012) 86.20%
Household survey: Last DTP3 survey (2012) 88%
% districts achieving > 80% DTP3 coverage (2017) 100%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 90%

Breakdown of support

Non-vaccine support Vaccine support
17% 83%
$5,125,802 $25,570,129

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Gambia

11 July 2018

Every Child Counts The Gambia programme

Shifo & Gavi join hands to help make vaccines work for every child

The Shifo Foundation, in collaboration with Gavi and other key partners will work to strengthen registration and data quality across The Gambia and ensure no child misses out on life-saving vaccines.

07 May 2018

Rwanda - FB Live

New management training for immunisation leaders kicks-off in Kigali

24 managers from five Gavi-supported countries will attend the first round of the nine-month programme.

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

close icon

modal window here